Sulzberger Gabrielle - Insider Non-Derivative Transactions at Cerevel Therapeutics Holdings, Inc. (CERE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 1, 2024, Sulzberger Gabrielle's relationship to Cerevel Therapeutics Holdings, Inc. (CERE) is Director, and currently has 10,461 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CERE insiders.
Data Source: SEC.
Sulzberger Gabrielle - Insider Non-Derivative Transactions of CERE Common Stock
Sulzberger Gabrielle - Insider Non-Derivative Transactions at CERE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 2, 2024 | Disposition -- (Common Stock) | 10461 | 0 | 0 |
| Aug 2, 2024 | Disposition -- (Common Stock) | 48415 | 0 | 10461 |
| Jun 6, 2024 | Acquisition -- (Common Stock) | 10461 | 0 | 58876 |
| Aug 30, 2023 | G -- (Common Stock) | 562 | 0 | 48415 |
| Jun 8, 2023 | Acquisition -- (Common Stock) | 3282 | 0 | 47853 |
| Oct 4, 2022 | G -- (Common Stock) | 49624 | 0 | 14270 |